Investors have handed the reins of an out-of-state biotech company — along with $40 million in fresh capital — to the former C-suite of San Diego’s short-lived Laguna Pharmaceuticals...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129